MORPHINE SULFATE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Mar 17, 2008

   18 yr 6 mo ago

2. Today

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• ARYMO ERBrand (NDA)

  NDA 208603 · ZYLA

  2017
• MORPHABOND ERBrand (NDA)

  NDA 206544 · OHEMO LIFE

  2015
• MORPHINE SULFATEBrand (NDA)

  NDA 204223 · FRESENIUS KABI USA

  2013
• MORPHINE SULFATEBrand (NDA)

  NDA 202515 · HOSPIRA INC

  2011
• MORPHINE SULFATEBrand (NDA)

  NDA 201517 · CHARTWELL MOLECULAR

  2011
• KADIANBrand (NDA)

  NDA 020616 · ALLERGAN

  2007
• DEPODURBrand (NDA)

  NDA 021671 · PACIRA PHARMS INC

  2004
• AVINZABrand (NDA)

  NDA 021260 · KING PHARMS LLC

  2002
• MORPHINE SULFATEBrand (NDA)

  NDA 020631 · SPECGX LLC

  1996
• MORPHINE SULFATEBrand (NDA)

  NDA 019917 · ICU MEDICAL INC

  1992
• MORPHINE SULFATEBrand (NDA)

  NDA 019916 · ICU MEDICAL INC

  1992
• MORPHINE SULFATE (AUTOINJECTOR)Brand (NDA)

  NDA 019999 · MERIDIAN MEDCL TECHN

  1990

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.